|
Mr. Hage joined Novavax in 2004 as Vice President of Marketing and Corporate Development from CHS Incorporated where he was an independent marketing consultant to the pharmaceutical industry. Prior to his work with CHS Mr. Hage was the Director of Marketing at Cephalon Inc. where his focus was on product marketing and development in the central nervous system (CNS) therapeutic area. From 1992 to 2002 Mr. Hage was with Eli Lilly and Company most recently as Director of Marketing for Evista Lilly’s successful osteoporosis drug for post-menopausal women. During his tenure at Lilly Mr. Hage also held various sales and marketing management positions. Mr. Hage has an MBA from The Ohio State University Fisher College of Business and a BS in Business and Economics from the University of Kentucky. | 